Harvey Partners’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.3M Sell
756,832
-49,168
-6% -$2.41M 2.69% 16
2026
Q1
$34.4M Buy
806,000
+63,954
+9% +$2.66M 2.74% 14
2025
Q4
$29.3M Buy
742,046
+546
+0.1% +$21.6K 2.59% 17
2025
Q3
$30.8M Buy
741,500
+32,114
+5% +$1.42M 2.74% 16
2025
Q2
$33.2M Buy
709,386
+48,386
+7% +$1.98M 3.25% 11
2025
Q1
$26.4M Buy
661,000
+68,500
+12% +$2.67M 3.08% 13
2024
Q4
$22.7M Buy
592,500
+85,500
+17% +$3.41M 2.52% 15
2024
Q3
$20.2M Buy
507,000
+64,500
+15% +$2.7M 2.3% 18
2024
Q2
$17.5M Buy
442,500
+97,500
+28% +$3.79M 2.1% 25
2024
Q1
$13.5M Buy
345,000
+182,000
+112% +$7.16M 1.43% 33
2023
Q4
$6.45M Buy
+163,000
New +$5.95M 0.73% 35

Other funds holding BATRK

Harvey Partners's BATRK Position: Q2 2026 in Review

Harvey Partners reduced its Atlanta Braves Holdings Series B (BATRK) stake by 6.1% in Q2 2026, selling an estimated $2.41M and leaving 756,832 shares worth $39.3M. The position accounts for 2.69% of the portfolio, ranked #16.

Harvey Partners first reported a position in BATRK in Q4 2023 and has held it in 11 quarters since. 325 funds tracked by Wall St. Rank hold BATRK as of Q2 2026.

  • Harvey Partners held 756,832 shares of Atlanta Braves Holdings Series B worth $39.3M as of Q2 2026.
  • Harvey Partners sold 49,168 Atlanta Braves Holdings Series B shares in Q2 2026, an estimated $2.41M.
  • Atlanta Braves Holdings Series B made up 2.69% of Harvey Partners's portfolio in Q2 2026, its #16 holding.
  • Harvey Partners first reported a position in Atlanta Braves Holdings Series B in Q4 2023 and has held it in 11 quarters since.
  • 325 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q2 2026.

Based on Harvey Partners's 13F filing for Q2 2026, filed 14 Aug 2026.